Key Findings

The study identifies the class C beta-lactamase from Acinetobacter baumannii (blaADC) as a target for inhibitor design. The boronic acid derivatives, particularly compound 5, show potent inhibition of blaADC, reducing MICs of ceftazidime and cefotaxime in E. coli DH10B.